Osteonic오스테오닉
226400 · KOSDAQ · ₩226400 · 오스테오닉
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
₩6,788
vs the current price (₩4,060)
- Enterprise value
- ₩156B
- Equity value
- ₩141B
- WACC
- 6.8%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model is 67% away from today's price. A gap this size usually means the market expects something the past figures don't show yet, or the model leaves something out. What we can see:
- To match today's price of ₩4,060, the model needs an operating margin of 12.7% every year (it uses 17.0%).
- Or revenue growth −12.2 points a year higher than assumed in each of the 5 years.
- Margins ranged from 3.7% to 20.1% over the last 5 years, so this is a cyclical business. The model uses the average; the price may be set by where the cycle is now. Try the margin fade option.
- 33% of the last 12 months' net profit came from outside operations (stakes in other companies, interest, one-offs). The model adds those stakes at book value but doesn't project that income.
- Today's P/E is 8.3× against a typical 21.0× over the last 10 years.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- ₩3,780
- −6.9%
- Base
- ₩6,788
- +67.2%
- Bull
- ₩12,055
- +196.9%
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (17.0%).
Revenue growth
- 25%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (31.8% a year, annual reports), fading to 3% by year 5.
- 19.5%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (31.8% a year, annual reports), fading to 3% by year 5.
- 14%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (31.8% a year, annual reports), fading to 3% by year 5.
- 8.5%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (31.8% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (31.8% a year, annual reports), fading to 3% by year 5.
Business
- 17%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 17.4%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).
- 21.8%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- 40%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.01%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-30.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 105 weeks of weekly returns against KOSPI (official index); raw beta -0.03, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.51%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩51B
- Net debt (borrowings and leases − cash and deposits)
- ₩15B
- − Minority interests
- ₩116M
- Shares
- 20,768,101
- Share price
- ₩4,060
- Market cap
- ₩84B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩28B | ₩34B | ₩45B | ₩64B | ₩76B | ₩87B | ₩94B | ₩97B |
| Growth | 40.1% | 23.2% | 32.6% | 25.0% | 19.5% | 14.0% | 8.5% | 3.0% |
| EBIT | ₩4.8B | ₩6.9B | ₩8.9B | ₩11B | ₩13B | ₩15B | ₩16B | ₩16B |
| EBIT margin | 17.4% | 20.1% | 19.5% | 17.0% | 17.0% | 17.0% | 17.0% | 17.0% |
| After-tax EBIT | ₩3.5B | ₩5B | ₩6.4B | ₩7.9B | ₩9.4B | ₩11B | ₩12B | ₩12B |
| + Depreciation | — | — | — | ₩11B | ₩13B | ₩15B | ₩16B | ₩17B |
| − Capital spending | ₩7B | ₩7.1B | ₩9B | ₩14B | ₩17B | ₩19B | ₩21B | ₩21B |
| − Working capital | ₩11B | ₩8.7B | ₩1.3B | ₩5.1B | ₩5B | ₩4.3B | ₩3B | ₩1.1B |
| Free cash flow | — | — | — | −₩48M | ₩1.1B | ₩2.6B | ₩4.5B | ₩6.6B |
| Discount factor | — | — | — | 0.936 | 0.876 | 0.821 | 0.768 | 0.719 |
| Present value | — | — | — | −₩45M | ₩933M | ₩2.1B | ₩3.5B | ₩4.7B |
Terminal value ₩201B, worth ₩145B today: 93% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩3,464 a share)Now 1.17× | ₩5,0271.45× | ₩7,1072.05× | ₩8,3912.42× |
| Price / earnings (last 12 months: ₩491 a share)Now 8.26× | ₩4,5259.21× | ₩10,33221.0× | ₩13,77528.0× |
| P/E on run-rate earnings (Q2 2026 × 4: ₩351 a share)Now 11.6× | ₩3,2309.21× | ₩7,37521.0× | ₩9,83228.0× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 5.8% | ₩7,368 | ₩8,116 | ₩9,058 | ₩10,282 | ₩11,939 |
| 6.3% | ₩6,491 | ₩7,073 | ₩7,790 | ₩8,692 | ₩9,864 |
| 6.8% | ₩5,767 | ₩6,230 | ₩6,788 | ₩7,473 | ₩8,337 |
| 7.3% | ₩5,160 | ₩5,534 | ₩5,977 | ₩6,510 | ₩7,166 |
| 7.8% | ₩4,644 | ₩4,950 | ₩5,307 | ₩5,731 | ₩6,241 |
Now (TTM)
- Market cap
- ₩84B
- Enterprise value
- ₩94B
- P/E
- 8.3×
- P/B
- 1.2×
- P/S
- 1.7×
- EV/EBITDA
- —
- Dividend yield
- 0.0%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Price | ₩6,220 | ₩6,500 | ₩4,820 | ₩3,165 | ₩3,565 |
| Market cap | ₩129B | ₩135B | ₩100B | ₩66B | ₩74B |
| P/E | 17.2× | 23.9× | 27.4× | 78.7× | — |
| P/B | 1.9× | 2.3× | 1.9× | 1.8× | 2.1× |
| P/S | 2.8× | 3.9× | 3.6× | 3.3× | 4.7× |
| EV/EBITDA | — | — | — | — | — |
| Dividend yield | 0.0% | — | — | — | — |
Versus similar companies
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: Osteonic / 오스테오닉 / 226400 / KRX:226400
Source: KRX statistical information